Iovance Biotherapeutics Inc (IOVA) financials · rev $263.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Iovance Biotherapeutics Inc (IOVA) rev $263.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $263.5M | $164.1M |
| Cost of Revenue | $173.2M | $124.0M |
| Gross Profit | $90.3M | $40.1M |
| Operating Income | -$403.4M | -$395.3M |
| Net Income | -$391.0M | -$372.2M |
| EPS (Diluted) | -$1.09 | -$1.28 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $913.2M | $910.4M |
| Current Assets | $442.7M | $457.0M |
| Cash & Equivalents | $163.1M | $115.7M |
| Inventory | $51.7M | $51.5M |
| PP&E | $131.1M | $109.1M |
| Total Liabilities | $214.6M | $200.0M |
| Current Liabilities | $138.4M | $122.3M |
| Shareholders' Equity | $698.6M | $710.4M |
| Retained Earnings | -$2.78B | -$2.38B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$302.4M | -$353.0M |
| CapEx | $33.8M | $11.1M |
| Investing Cash Flow | $47.5M | -$96.4M |
| Financing Cash Flow | $300.8M | $390.7M |
| Net Change in Cash | $47.0M | -$59.3M |
| Free Cash Flow | -$336.2M | -$364.0M |
FAQ
What is IOVA P/E and revenue?
Iovance Biotherapeutics Inc (IOVA) rev $263.5M.
What is IOVA revenue?
Iovance Biotherapeutics Inc last cached revenue is $263.5M (FY2025).
Is IOVA profitable?
Iovance Biotherapeutics Inc last cached net income is -$391.0M (FY2025).
What are IOVA total assets?
Iovance Biotherapeutics Inc last cached total assets are $913.2M (FY2025).
What is IOVA free cash flow?
Iovance Biotherapeutics Inc last cached free cash flow is -$336.2M (FY2025).
Not investment advice. Cached statements, not a live tape.